Role of microRNA‑26a in the diagnosis of lower extremity deep vein thrombosis in patients with bone trauma

Li,Zi; Ni,Jiangdong

doi:10.3892/etm.2017.5183

Role of microRNA‑26a in the diagnosis of lower extremity deep vein thrombosis in patients with bone trauma

Authors:
- Zi Li
- Jiangdong Ni
View Affiliations

Affiliations: Department of Orthopedics, Xiangya Second Hospital of Central South University, Changsha, Hunan 410011, P.R. China
Published online on: September 22, 2017 https://doi.org/10.3892/etm.2017.5183
Pages: 5069-5074

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the role and mechanism of action of microRNA (miR)‑26a in deep vein thrombosis (DVT). Peripheral blood was collected from 45 patients with DVT and 40 healthy controls. Levels of miR‑26a, chemokine C‑C motif ligand (CCL)2 mRNA and CCL7 mRNA were detected using reverse transcription‑quantitative polymerase chain reaction and the value of miR‑26a in the clinical diagnosis of DVT was assessed using receiver operating characteristic curve analysis. The correlation of miR‑26a with CCL2 and CCL7 levels was analyzed using Spearman's rank correlation. In addition, miR‑26a and protein kinase C δ (PRKCD) were overexpressed in human umbilical vein endothelial cells (HUVECs) and PRKCD expression was knocked down by small interfering (si)RNA. Western blotting was conducted to detect the expression of PRKCD and p65. Furthermore, a dual‑luciferase reporter gene assay was performed. The results of the current study demonstrated that the expression of miR‑26a was significantly downregulated in the peripheral blood of patients with DVT compared with healthy controls (P<0.05) and negatively correlated with CCL2 and CCL7 levels (P<0.05). Furthermore, it was demonstrated that miR‑26a markedly inhibited the expression of PRKCD, significantly decreased levels of CCL2 and CCL7 mRNA (P<0.05) and inhibited activation of the NF‑κB signaling pathway. Overexpression of PRKCD in HUVECs inhibited the effects of miR‑26a and markedly upregulated the phosphorylation of p65. The present study indicated that miR‑26a directly targets PRKCD mRNA and that miR‑26a may be a useful biomarker in the clinical diagnosis of DVT. Thus, the present findings suggest that miR‑26a regulates the NF‑κB signaling pathway by binding to PRKCD mRNA, inhibits the expression of CCL2 and CCL7 and reduces the risk of DVT.

View Figures

View References

1	van Hylckama Vlieg A and Baglin TP: The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: Results of the THE-VTE study: Reply. J Thromb Haemost. 13:2286–2287. 2015. View Article : Google Scholar : PubMed/NCBI
2	Van der Hulle T, den Exter PL, Planquette B, Meyer G, Soler S, Monreal M, Jiménez D, Portillo AK, O'Connell C and Liebman HA: Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism amongst treated and untreated patients: A pooled analysis of 926 patients. J Thromb Haemost. 14:105–113. 2016. View Article : Google Scholar : PubMed/NCBI
3	Hossam Abdel-Hamid, Jonathan Miles, Richard W J. Carrington, Alister Hart, Alex Loh, John A and Skinner: Combined vascular and orthopedic approach for a pseudotumor causing deep vein thrombosis after metal-on-metal hip resurfacing arthroplasty. Case Rep Orthop. 2015:9262632015.PubMed/NCBI
4	Hattab Y, Küng S, Fasanya A, Ma K, Singh AC and DuMont T: Deep venous thrombosis of the upper and lower extremity. Crit Care Nurs Q. 40:230–236. 2017. View Article : Google Scholar : PubMed/NCBI
5	Cho SY, Youn HJ, Park MY, Shim BJ, Lee SJ, Kim JH, Park JK, Oh CY, Ahn SH and Cho WH: Post-operative multiple thrombosis associated with patent foramen ovale: Embolic stroke, right atrial thrombi, pulmonary embolism and deep vein thrombosis. J Cardiovasc Ultrasound. 23:177–180. 2015. View Article : Google Scholar : PubMed/NCBI
6	Ahn S, Kim MH, Jun KW, Hwang JK, Park SC, Moon IS and Kim JI: The incidence and risk factors of deep vein thrombosis after kidney transplantation in Korea: Single center experience. Clin Transplant. 29:1181–1186. 2015. View Article : Google Scholar : PubMed/NCBI
7	Alderman BE, de Boisanger J and Bottomley T: Hypoplasia of the inferior vena cava in a young man presenting with extensive deep venous thrombosis. BMJ Case Rep 2015. pii bcr2015211849. 2015. View Article : Google Scholar
8	Park SI, Lee M, Lee MS, Kim MD, Won JY and Lee DY: Single-session aspiration thrombectomy of lower extremity deep vein thrombosis using large-size catheter without pharmacologic thrombolysis. Cardiovasc Intervent Radiol. 37:412–419. 2014. View Article : Google Scholar : PubMed/NCBI
9	Gholami K, Talasaz AH, Entezari-Maleki T, Salarifar M, Hadjibabaie M, Javadi MR, Dousti S, Hamishehkar H and Maleki S: The effect of high-dose vitamin D3 on soluble p-selectin and hs-crp level in patients with venous thromboembolism: A randomized clinical trial. Clin Appl Thromb Hemost. 22:483–489. 2016. View Article : Google Scholar : PubMed/NCBI
10	Du T and Tan Z: Relationship between deep venous thrombosis and inflammatory cytokines in postoperative patients with malignant abdominal tumors. Braz J Med Biol Res. 47:1003–1007. 2014. View Article : Google Scholar : PubMed/NCBI
11	Entezari-Maleki T, Talasaz A Hajhossein, Salarifar M, Hadjibabaie M, Javadi MR, Bozorgi A, Jenab Y, Boroumand MA and Gholami K: Plasma VITAMIN D status and its correlation with risk factors of thrombosis, P-selectin and hs-CRP level in patients with venous thromboembolism; the first study of Iranian population. Iran J Pharm Res. 13:319–327. 2014.PubMed/NCBI
12	Stypińska B and Paradowska-Gorycka A: Cytokines and MicroRNAs as candidate biomarkers for systemic lupus erythematosus. Int J Mol Sci. 16:24194–24218. 2015. View Article : Google Scholar : PubMed/NCBI
13	Zhu W, Qian J, Ma L, Ma P, Yang F and Shu Y: MiR-346 suppresses cell proliferation through SMYD3 dependent approach in hepatocellular carcinoma. Oncotarget. May 22–2017.doi: 10.18632/oncotarget.18060. (Epub ahead of print).
14	Iwakawa HO and Tomari Y: The functions of MicroRNAs: mRNA decay and translational repression. Trends Cell Biol. 25:651–665. 2015. View Article : Google Scholar : PubMed/NCBI
15	Huang YK and Yu JC: Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. World J Gastroenterol. 21:9863–9886. 2015. View Article : Google Scholar : PubMed/NCBI
16	He Y, Lin J, Kong D, Huang M, Xu C, Kim TK, Etheridge A, Luo Y, Ding Y and Wang K: Current state of circulating MicroRNAs as cancer biomarkers. Clin Chem. 61:1138–1155. 2015. View Article : Google Scholar : PubMed/NCBI
17	Libânio D, Dinis-Ribeiro M and Pimentel-Nunes P: Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions. World J Clin Oncol. 6:111–132. 2015. View Article : Google Scholar : PubMed/NCBI
18	Sakimoto T and Ishimori A: Anti-inflammatory effect of topical administration of tofacitinib on corneal inflammation. Exp Eye Res. 145:110–117. 2015. View Article : Google Scholar : PubMed/NCBI
19	Schaefer JK, Jacobs B, Wakefield TW and Sood SL: New biomarkers and imaging approaches for the diagnosis of deep venous thrombosis. Curr Opin Hematol. 24:274–281. May;2017. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-tie quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Kim JH, Jeon S and Shin BA: MicroRNA-29 family suppresses the invasion of HT1080 human fibrosarcoma cells by regulating matrix metalloproteinase 2 expression. Chonnam Med J. 53:161–167. May;2017. View Article : Google Scholar : PubMed/NCBI
22	Bardina SV, Michlmayr D, Hoffman KW, Obara CJ, Sum J, Charo IF, Lu W, Pletnev AG and Lim JK: Differential roles of chemokines CCL2 and CCL7 in monocytosis and leukocyte migration during west nile virus infection. J Immunol. 195:4306–4318. 2015. View Article : Google Scholar : PubMed/NCBI
23	Cummings R, Zhao Y, Jacoby D, Spannhake EW, Ohba M, Garcia JG, Watkins T, He D, Saatian B and Natarajan V: Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells. J Biol Chem. 279:41085–41094. 2004. View Article : Google Scholar : PubMed/NCBI
24	Abdalla G, Matuk R Fawzi, Venugopal V, Verde F, Magnuson TH, Schweitzer MA and Steele KE: The diagnostic accuracy of magnetic resonance venography in the detection of deep venous thrombosis: A systematic review and meta-analysis. Clin Radiol. 70:858–871. 2015. View Article : Google Scholar : PubMed/NCBI
25	Friedmann DP, Liolios AM, Wu DC, Goldman MP and Eimpunth S: A randomized, double-blind, placebo-controlled study of the effect of a high-potency topical corticosteroid after sclerotherapy for reticular and telangiectatic veins of the lower extremities. Dermatol Surg. 41:1158–1163. Oct;2015. View Article : Google Scholar : PubMed/NCBI
26	Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI and Vargas-Castrillón E: Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: An evidence-based review. Vasc Health Risk Manag. 10:627–639. 2014. View Article : Google Scholar : PubMed/NCBI
27	Olszewski WL, Zaleska M, Stelmach E, Swoboda-Kopec E, Jain P, Agrawal K, Gogia S, Gogia A, Andziak P and Durlik M: Cryptic bacteria of lower limb deep tissues as a possible cause of inflammatory and necrotic changes in ischemia, venous stasis and varices and lymphedema. Surg Infect (Larchmt). 16:313–322. 2015. View Article : Google Scholar : PubMed/NCBI
28	Saghazadeh A, Hafizi S and Rezaei N: Inflammation in venous thromboembolism: Cause or consequence? Int Immunopharmacol. 28:655–665. 2015. View Article : Google Scholar : PubMed/NCBI
29	Jenkins JS and Michael P: Deep venous thrombosis: An interventionalist's approach. Ochsner J. 14:633–640. 2014.PubMed/NCBI
30	Krieger E, Van der Loo B, Amann-Vesti BR, Rousson V and Koppensteiner R: C-reactive protein and red cell aggregation correlate with late venous function after acute deep venous thrombosis. J Vasc Surg. 40:644–649. 2004. View Article : Google Scholar : PubMed/NCBI
31	Sawant DV, Wu H, Kaplan MH and Dent AL: The Bcl6 target gene microRNA-21 promotes Th2 differentiation by a T cell intrinsic pathway. Mol Immunol. 54:435–442. 2013. View Article : Google Scholar : PubMed/NCBI
32	Lu S, Jiao H, Xu J, Zheng Y, Sun Y and Chen H: Downregulation of IL6 targeted MiR-376b may contribute to a positive IL6 feedback loop during early liver regeneration in mice. Cell Physiol Biochem. 37:233–242. 2015. View Article : Google Scholar : PubMed/NCBI
33	Xie Q, Wei M, Kang X, Liu D, Quan Y, Pan X, Liu X, Liao D, Liu J and Zhang B: Reciprocal inhibition between miR-26a and NF-κB regulates obesity-related chronic inflammation in chondrocytes. Biosci Rep. 35:pii e002042015.
34	Bauer D, Redmon N, Mazzio E, Taka E, Reuben JS, Day A, Sadrud-Din S, Flores-Rozas H, Soliman KF and Darling-Reed S: Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling. Cytokine. 75:117–126. 2015. View Article : Google Scholar : PubMed/NCBI
35	Gao X, Huang W, Zhang X, Du S, Wang J, Wang W, Zhou M, Chen S, Li X and Jonas JB: Chemokine (C-C motif) ligand 2 and chemokine (C-C motif) ligand 7 in angle-closure glaucoma. Acta Ophthalmol. 94:e220–e224. 2016. View Article : Google Scholar : PubMed/NCBI